SCHEMBL2443389

SCHEMBL2443389

C#CC(C)(C)N(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL31083339 0.97
Butynamine SCHEMBL2109905 0.73
SCHEMBL14372109 0.66
SCHEMBL25319601 0.66
SCHEMBL11854358 0.66
SCHEMBL2277776 0.65
SCHEMBL299989 0.64
SCHEMBL1726984 0.64
SCHEMBL29854 0.62
SCHEMBL16804666 0.62 LMNA (0.55)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008107321-A1 HETEROCYCLIC COMPOUNDS USED AS ANTI-NEOPLASIC AGENTS OR CELL PROLIFERATION INHIBITORS CEREP (FR) 2008-09-12 WO claimed
WO-2026041636-A1 MACROCYCLE COMPOUNDS FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2026-02-26 WO disclosed
CN-119823103-A Polycyclic derivative inhibitor, preparation method and application thereof 江苏豪森药业集团有限公司 2025-04-15 CN disclosed
WO-2024245193-A1 HETEROAROMATIC RING COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF 上海艾力斯医药科技股份有限公司 2024-12-05 WO disclosed
US-20240307406-A1 Device for determining the attitude of a carrier, and associated system for assisting with the piloting of a carrier and determination method ADVANCED BIODESIGN (FR) 2024-09-19 US disclosed
CN-117320706-A Aminothiol ester compounds or derivatives thereof as immunomodulators 高级生物设计公司 2023-12-29 CN disclosed
EP-4284360-A1 AMINOTHIOLESTER COMPOUND OR DERIVATIVE THEREOF FOR USE AS AN IMMUNOMODULATORY AGENT Advanced Biodesign (FR) 2023-12-06 EP disclosed
US-20220363666-A1 TYROSINE KINASE INHIBITOR COMPOSITIONS, METHODS OF MAKING AND METHODS OF USE BLACK DIAMOND THERAPEUTICS, INC. (US) 2022-11-17 US disclosed
US-20220265845-A1 AMINOTHIOLESTER COMPOUNDS AND USES THEREOF ADVANCED BIODESIGN (FR) 2022-08-25 US disclosed
WO-2022162196-A1 AMINOTHIOLESTER COMPOUND OR DERIVATIVE THEREOF FOR USE AS AN IMMUNOMODULATORY AGENT ADVANCED BIODESIGN (FR) 2022-08-04 WO disclosed
WO-2008107321-A1 HETEROCYCLIC COMPOUNDS USED AS ANTI-NEOPLASIC AGENTS OR CELL PROLIFERATION INHIBITORS CEREP (FR) 2008-09-12 WO disclosed
US-20070032476-A1 Aminothiolester compounds, pharmaceutical and cosmetic compositions containing same and uses thereof CNRS - CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2007-02-08 US disclosed
US-7078402-B2 Aminothiol ester compounds, pharmaceutical and cosmetics compositions containing same and uses thereof CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 2006-07-18 US disclosed
EP-1296946-B1 AMINOTHIOLESTER COMPOUNDS, PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING SAME AND USES THEREOF GALDERMA RES & DEV (FR) 2004-04-21 EP disclosed
US-20030181443-A1 Aminothiolester compounds, pharmaceutical and cosmetic compositions containing same and uses thereof ADVANCED BIODESIGN (FR) 2003-09-25 US disclosed
EP-1296946-A1 AMINOTHIOLESTER COMPOUNDS, PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING SAME AND USES THEREOF Galderma Research & Development, S.N.C. (FR) 2003-04-02 EP disclosed
WO-2001092220-A1 AMINOTHIOLESTER COMPOUNDS, PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING SAME AND USES THEREOF GALDERMA RESEARCH & DEVELOPMENT, S.N.C. (FR) 2001-12-06 WO disclosed
US-5789448-A TYROSINE KINASE INHIBITORS; ANTICARCINOGENIC AGENTS; SIDE EFFECT REDUCTION MITSUBISHI CHEMICAL CORPORATION (JP) 1998-08-04 US disclosed
EP-0721930-A1 BENZOYLETHYLENE DERIVATIVE MITSUBISHI CHEMICAL CORPORATION (JP) 1996-07-17 EP disclosed
US-3969415-A ANTIINFLAMMATORY SANDOZ, INC. (US) 1976-07-13 US disclosed